HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia.

AbstractOBJECTIVE:
To investigate the specificity of in vivo amyloid imaging with [(11)C]-Pittsburgh Compound B (PIB) in Parkinson disease dementia (PDD).
METHODS:
We performed detailed neuropathologic examination for 3 individuals with PDD who had PIB PET imaging within 15 months of death.
RESULTS:
We observed elevated cortical uptake of [(11)C]-PIB on in vivo PET imaging in 2 of the 3 cases. At autopsy, all 3 individuals had abundant cortical Lewy bodies (Braak PD stage 6), and were classified as low-probability Alzheimer disease (AD) based on NIA-Reagan criteria. The 2 PIB-positive individuals had abundant diffuse Abeta plaques but only sparse neuritic plaques and intermediate neurofibrillary tangle pathology. The PIB-negative individual had rare diffuse plaques, no neuritic plaques, and low neurofibrillary tangle burden.
CONCLUSIONS:
[(11)C]-Pittsburgh Compound B (PIB) PET is specific for fibrillar Abeta molecular pathology but not for pathologic diagnosis of comorbid Alzheimer disease in individuals with Parkinson disease dementia. The ability to specifically identify fibrillar Abeta amyloid in the setting of alpha-synucleinopathy makes [(11)C]-PIB PET a valuable tool for prospectively evaluating how the presence of Abeta amyloid influences the clinical course of dementia in patients with Lewy body disorders.
AuthorsM A Burack, J Hartlein, H P Flores, L Taylor-Reinwald, J S Perlmutter, N J Cairns
JournalNeurology (Neurology) Vol. 74 Issue 1 Pg. 77-84 (Jan 05 2010) ISSN: 1526-632X [Electronic] United States
PMID20038776 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
  • Amyloid
  • Amyloid beta-Peptides
  • Aniline Compounds
  • Carbon Radioisotopes
  • Thiazoles
  • alpha-Synuclein
  • tau Proteins
Topics
  • Amyloid (metabolism)
  • Amyloid beta-Peptides (metabolism)
  • Aniline Compounds
  • Autopsy (methods)
  • Brain Mapping
  • Carbon Radioisotopes
  • Cerebral Cortex (pathology)
  • Dementia (complications, diagnostic imaging)
  • Female
  • Humans
  • Lewy Bodies (diagnostic imaging)
  • Male
  • Mental Status Schedule
  • Neurofibrillary Tangles (diagnostic imaging, pathology)
  • Parkinson Disease (complications, diagnostic imaging)
  • Positron-Emission Tomography (methods)
  • Prospective Studies
  • Protein Binding
  • Severity of Illness Index
  • Thiazoles
  • alpha-Synuclein (metabolism)
  • tau Proteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: